Qvin, a biotechnology research company that has developed a healthcare service that collects menstrual blood samples as an alternative to traditionally collected venous blood draws, has received US Food and Drug Administration clearance of its Q-Pad and A1c Test.
For the full story, see the February 2024 edition of Medical Textiles.
Image: Qvin